EGM
VERA icon

Engineers Gate Manager’s Vera Therapeutics VERA Stock Holding History

Engineers Gate Manager’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.64M Buy
108,139
+101,699
+1,579% +$3.79M 0.06% 364
2026
Q1 		$259K Buy
+6,440
New +$277K ﹤0.01% 1784
2025
Q4 		– Sell
-22,138
Closed -$643K – 2578
2025
Q3 		$643K Buy
+22,138
New +$512K 0.01% 1402
2025
Q2 		– Sell
-42,873
Closed -$1.03M – 2567
2025
Q1 		$1.03M Buy
+42,873
New +$1.38M 0.02% 1041
2024
Q3 		– Sell
-19,524
Closed -$706K – 2429
2024
Q2 		$706K Buy
+19,524
New +$774K 0.02% 1060

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Engineers Gate Manager's VERA Position: Q2 2026 in Review

Engineers Gate Manager increased its Vera Therapeutics (VERA) stake by 1,579% in Q2 2026, buying an estimated $3.79M and bringing the position to 108,139 shares worth $4.64M. The position accounts for 0.06% of the portfolio, ranked #364.

Engineers Gate Manager first reported a position in VERA in Q2 2024 and has held it in 5 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Engineers Gate Manager held 108,139 shares of Vera Therapeutics worth $4.64M as of Q2 2026.
  • Engineers Gate Manager bought 101,699 Vera Therapeutics shares in Q2 2026, an estimated $3.79M.
  • Vera Therapeutics made up 0.06% of Engineers Gate Manager's portfolio in Q2 2026, its #364 holding.
  • Engineers Gate Manager first reported a position in Vera Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.